摘要
Catalytic ozonation is an effective method for wastewater purification. However, the low transfer of ozone in packed bubble columns leads to low ozone utilization efficiency, limited organic degradation, and high energy consumption. To address these issues, activated carbon supported catalysts, such as CuMn2O4@WAC and CuMn2O4@CSAC, have been developed, which exhibit excellent catalytic activity, stability, and high ozone utilization efficiency for the degradation of IBP in pharmaceutical wastewater. The addition of CuMn2O4@WAC or CuMn2O4@CSAC significantly increased the removal efficiency of IBP from 85% to 99%, while reducing energy consumption from 2.86 kW h m−3 to 0.80 kW h m−3 or 1.11 kW h m−3, respectively. Carboxyl groups on the surface of AC and oxygen vacancies on CuMn2O4 are key active sites for ozone adsorption and decomposition. Additionally, DFT calculations revealed that Mn–OV sites on CuMn2O4 play a crucial role in these processes, where ozone is adsorbed and decomposed into atomic oxygen and peroxide. The synergy between activated carbon supported CuMn2O4 enhances mass transfer and promotes ozone decomposition, generating highly reactive species that effectively degrade IBP in pharmaceutical wastewater. Overall, utilizing activated carbon supported CuMn2O4 for catalytic ozonation presents a promising approach for pharmaceutical wastewater treatment.
危险品化学品经营许可证(带存储)